Active Ingredient(s): Emtricitabine + Tenofovir Alafenamide
FDA Approved: * April 4, 2016
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Descovy Overview

Emtricitabine/tenofovir, sold under the brand name Truvada among others, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS.[2][3] It contains the antiretroviral medications emtricitabine and tenofovir disoproxil.[4] For treatment, it must be used in combination with other antiretroviral medications.[4][5] For prevention before exposure, in those who are at high risk, it is re...

Read more Descovy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Descovy Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Emtricitabine + Tenofovir Alafenamide
  • Tablet: 100mg + 150mg, 133mg + 200mg, 167mg + 250mg, 200mg + 25mg, 200mg + 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Descovy: (2 results)

Sorted by National Drug Code
  • 61958-2002 Descovy Oral Tablet by Gilead Sciences, Inc.
  • 70518-0230 Descovy Oral Tablet by Remedyrepack Inc.

Drugs with one or more similar ingredients: (18 results)